Research programme: type 2 diabetes mellitus therapy - deCODE genetics
Latest Information Update: 04 Nov 2017
At a glance
- Originator deCODE genetics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in Europe
- 08 Mar 2006 deCODE reported the discovery of the genetic risk factor for type 2 diabetes in the gene on chromosome 10 encoding transcription factor 7-like 2 (TCF7L2)
- 23 Aug 2005 This programme is still in active development